Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ryan C. McComb"'
Autor:
Christopher K. Cote, Jennifer E. Peel, Samandra T. Demons, Jennifer K Tran, Lynda L. Miller, Chi-Lee C. Ho, Satheesh K Sivasubramani, Chiu-Yen Kao, Jennifer L. Shoe, David P Fetterer, Mikhail Martchenko Shilman, Johnny W. Peterson, Gloria Bartolo, Ryan C. McComb, Saleem Alameh, Kenneth A. Bradley, David W.C. Beasley, Stella Hartmann, Emiene Amali-Adekwu, William S Lawrence, Anastasia Levitin, Marina Chugunova, Joel West, Leeor Zilbermintz, Christopher P. Klimko, Luisa W. Cheng, Aram Derbedrossian, Stephanie A Halasahoris
Publikováno v:
ACS Infect Dis
[Image: see text] Anthrax is caused by Bacillus anthracis and can result in nearly 100% mortality due in part to anthrax toxin. Antimalarial amodiaquine (AQ) acts as a host-oriented inhibitor of anthrax toxin endocytosis. Here, we determined the phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df80135ee02f50492e189d514256fed9
https://doi.org/10.1021/acsinfecdis.1c00190
https://doi.org/10.1021/acsinfecdis.1c00190
Autor:
Mikhail Martchenko, Ryan C. McComb
Publikováno v:
Vaccine. 34:13-19
Anthrax is defined by the Centers for Disease Control and Prevention as a Category A pathogen for its potential use as a bioweapon. Current prevention treatments include Anthrax Vaccine Adsorbed (AVA). AVA is an undefined formulation of Bacillus anth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bbe0a26efaa8b16fb2e0a658df97e44
https://doi.org/10.1016/j.vaccine.2015.11.025
https://doi.org/10.1016/j.vaccine.2015.11.025
Autor:
Ryan C McComb
This Restricted to Claremont Colleges Dissertation is brought to you for free and open access by the KGI Student Scholarship at Scholarship @ Claremont. It has been accepted for inclusion in KGI Theses and Dissertations by an authorized administrator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c738642612ca5c13c9f556770f658122
https://doi.org/10.5642/kgitd/3
https://doi.org/10.5642/kgitd/3
Publikováno v:
Vaccine. 33(48)
The current anthrax vaccine requires improvements for rapidly invoking longer-lasting neutralizing antibody responses with fewer doses from a well-defined formulation. Designing antigens that target neutralizing antibody epitopes of anthrax protectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ccc80d4b9f519cef65418335a51d5f
https://pubmed.ncbi.nlm.nih.gov/26514421
https://pubmed.ncbi.nlm.nih.gov/26514421
Autor:
Sun-Young Jeong, Rouzbeh Zamani, Robert T. Clubb, Sina Bavari, Mikhail Martchenko, Kenneth A. Bradley, William Leonardi, Leeor Zilbermintz, Joel West, Veronica Soloveva, Vivek Gupta, Dima N. Gharaibeh, Anastasia Levitin, Chi-Lee C. Ho, Cary Retterer, Megan Sjodt, Stanley N. Cohen, Ryan C. McComb
Publikováno v:
Scientific Reports
A longstanding and still-increasing threat to the effective treatment of infectious diseases is resistance to antimicrobial countermeasures. Potentially, the targeting of host proteins and pathways essential for the detrimental effects of pathogens o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf7bbfc768fac0aa887723ebb3b19f9
https://pubmed.ncbi.nlm.nih.gov/26310922
https://pubmed.ncbi.nlm.nih.gov/26310922